10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission File Number 001-03761

TEXAS INSTRUMENTS INCORPORATED

(Exact Name of Registrant as Specified in Its Charter)

	Delaware	75-0289970
	(State of Incorporation)	(I.R.S. Employer Identification No.)
	12500 TI Boulevard, Dallas, Texas	75243
	(Address of principal executive offices)	(Zip Code)
Registrant’s telephone number, including area code 214-479-3773

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $1.00	TXN	The Nasdaq Global Select Market

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act			☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

923,523,523

Number of shares of Registrant’s common stock outstanding as of

April 20, 2021

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

PART I - FINANCIAL INFORMATION

ITEM 1. Financial statements

	For Three Months Ended
Consolidated Statements of Income	March 31,
(Millions of dollars, except share and per-share amounts)	2021		2020
Revenue	$	4,289	$	3,329
Cost of revenue (COR)	1,492		1,241
Gross profit	2,797		2,088
Research and development (R&D)	386		377
Selling, general and administrative (SG&A)	425		417
Acquisition charges	47		50
Operating profit	1,939		1,244
Other income (expense), net (OI&E)	46		25
Interest and debt expense	46		45
Income before income taxes	1,939		1,224
Provision for income taxes	186		50
Net income	$	1,753	$	1,174
Earnings per common share (EPS):
Basic	$	1.89	$	1.25
Diluted	$	1.87	$	1.24
Average shares outstanding (millions):
Basic	922		931
Diluted	935		943
A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend equivalents. Diluted EPS is calculated using the following:
Net income	$	1,753	$	1,174
Income allocated to RSUs	(8)		(6)
Income allocated to common stock for diluted EPS	$	1,745	$	1,168
See accompanying notes.

2

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

	For Three Months Ended
Consolidated Statements of Comprehensive Income	March 31,
(Millions of dollars)	2021		2020
Net income	$	1,753	$	1,174
Other comprehensive income (loss)
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($2) and ($3)	5		9
Recognized within net income, net of tax effect of ($3) and ($2)	8		8
Available-for-sale investments:
Unrealized gains, net of tax effect of $0 and $0	—		2
Other comprehensive income (loss), net of taxes	13		19
Total comprehensive income	$	1,766	$	1,193
See accompanying notes.

3

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

	March 31,		December 31,
Consolidated Balance Sheets	2021		2020
(Millions of dollars, except share amounts)
Assets
Current assets:
Cash and cash equivalents	$	2,442	$	3,107
Short-term investments	4,244		3,461
Accounts receivable, net of allowances of ($9) and ($11)	1,584		1,414
Raw materials	183		180
Work in process	980		964
Finished goods	727		811
Inventories	1,890		1,955
Prepaid expenses and other current assets	245		302
Total current assets	10,405		10,239
Property, plant and equipment at cost	5,967		5,781
Accumulated depreciation	(2,536)		(2,512)
Property, plant and equipment	3,431		3,269
Goodwill	4,362		4,362
Acquisition-related intangibles	105		152
Deferred tax assets	331		343
Capitalized software licenses	113		122
Overfunded retirement plans	235		246
Other long-term assets	657		618
Total assets	$	19,639	$	19,351
Liabilities and stockholders’ equity
Current liabilities:
Current portion of long-term debt	$	—	$	550
Accounts payable	567		415
Accrued compensation	388		767
Income taxes payable	278		134
Accrued expenses and other liabilities	467		524
Total current liabilities	1,700		2,390
Long-term debt	6,250		6,248
Underfunded retirement plans	130		131
Deferred tax liabilities	88		90
Other long-term liabilities	1,305		1,305
Total liabilities	9,473		10,164
Stockholders’ equity:
Preferred stock, $25 par value. Authorized – 10,000,000 shares; none issued	—		—
Common stock, $1 par value. Authorized – 2,400,000,000 shares
Shares issued – 1,740,815,939	1,741		1,741
Paid-in capital	2,391		2,333
Retained earnings	42,860		42,051
Treasury common stock at cost
Shares: March 31, 2021 – 817,573,099; December 31, 2020 – 821,461,787	(36,479)		(36,578)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(347)		(360)
Total stockholders’ equity	10,166		9,187
Total liabilities and stockholders’ equity	$	19,639	$	19,351
See accompanying notes.

4

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

	For Three Months Ended
Consolidated Statements of Cash Flows	March 31,
(Millions of dollars)	2021		2020
Cash flows from operating activities
Net income	$	1,753	$	1,174
Adjustments to net income:
Depreciation	179		186
Amortization of acquisition-related intangibles	47		50
Amortization of capitalized software	15		14
Stock compensation	61		63
Gains on sales of assets	(1)		—
Deferred taxes	8		(34)
Increase (decrease) from changes in:
Accounts receivable	(170)		(242)
Inventories	65		(2)
Prepaid expenses and other current assets	73		(88)
Accounts payable and accrued expenses	69		—
Accrued compensation	(379)		(353)
Income taxes payable	131		147
Changes in funded status of retirement plans	28		27
Other	(29)		(91)
Cash flows from operating activities	1,850		851
Cash flows from investing activities
Capital expenditures	(308)		(161)
Proceeds from asset sales	1		—
Purchases of short-term investments	(2,782)		(646)
Proceeds from short-term investments	2,000		1,638
Other	(20)		(5)
Cash flows from investing activities	(1,109)		826
Cash flows from financing activities
Proceeds from issuance of long-term debt	—		749
Repayment of debt	(550)		—
Dividends paid	(940)		(841)
Stock repurchases	(100)		(1,641)
Proceeds from common stock transactions	196		146
Other	(12)		(9)
Cash flows from financing activities	(1,406)		(1,596)
Net change in cash and cash equivalents	(665)		81
Cash and cash equivalents at beginning of period	3,107		2,437
Cash and cash equivalents at end of period	$	2,442	$	2,518
See accompanying notes.

5

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Notes to financial statements

1. Description of business, including segment and geographic area information

We design, make and sell semiconductors to electronics designers and manufacturers all over the world. We have two reportable segments, Analog and Embedded Processing, each of which represents groups of similar products that are combined on the basis of similar design and development requirements, product characteristics, manufacturing processes and distribution channels.

•Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing, discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog segment consists of two major product lines: Power and Signal Chain.

•Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific tasks and can be optimized for various combinations of performance, power and cost, depending on the application.

We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP® products, calculators and custom ASIC products.

Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not provided.

Segment information

	For Three Months Ended
	March 31,
	2021		2020
Revenue:
Analog	$	3,280	$	2,460
Embedded Processing	767		653
Other	242		216
Total revenue	$	4,289	$	3,329
Operating profit:
Analog	$	1,646	$	1,025
Embedded Processing	287		182
Other (a)	6		37
Total operating profit	$	1,939	$	1,244

(a)Includes acquisition charges and restructuring charges/other

6

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Geographic area information

The following geographic area information includes revenue, based on product shipment destination. The geographic revenue information does not necessarily reflect end demand by geography because our products tend to be shipped to the locations where our customers manufacture their products.

	For Three Months Ended
	March 31,
	2021		2020
Revenue:
United States	$	393	$	390
Asia (a)	2,858		2,027
Europe, Middle East and Africa	682		619
Japan	239		190
Rest of world	117		103
Total revenue	$	4,289	$	3,329

(a)Revenue from products shipped into China was $2.3 billion and $1.7 billion in the first quarters of 2021 and 2020, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

2. Basis of presentation and significant accounting policies and practices

Basis of presentation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2020. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended March 31, 2021 and 2020, and the Consolidated Balance Sheet as of March 31, 2021, are not audited but reflect all adjustments that are of a normal recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2020. The results for the three-month periods are not necessarily indicative of a full year’s results.

Significant accounting policies and practices

Earnings per share (EPS)

We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock.

7

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Computation and reconciliation of earnings per common share are as follows (shares in millions):

	For Three Months Ended March 31,
	2021					2020
	Net Income		Shares	EPS		Net Income		Shares	EPS
Basic EPS:
Net income	$	1,753				$	1,174
Income allocated to RSUs	(8)					(6)
Income allocated to common stock	$	1,745	922	$	1.89	$	1,168	931	$	1.25
Dilutive effect of stock compensation plans			13					12
Diluted EPS:
Net income	$	1,753				$	1,174
Income allocated to RSUs	(8)					(6)
Income allocated to common stock	$	1,745	935	$	1.87	$	1,168	943	$	1.24

Potentially dilutive securities representing 3 million and 9 million shares of common stock that were outstanding during the first quarters of 2021 and 2020, respectively, were excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-dilutive.

Derivatives and hedging

We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments.

We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A.

In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material.

We do not use derivatives for speculative or trading purposes.

Fair values of financial instruments

The fair values of our derivative financial instruments were not material as of March 31, 2021. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of March 31, 2021, the carrying value of long-term debt, including the current portion, was $6.25 billion, and the estimated fair value was $6.74 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.

3. Income taxes

Our estimated annual effective tax rate is about 14%, which does not include discrete tax items. This differs from the 21% U.S. statutory corporate tax rate due to the effect of U.S. tax benefits.

8

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Provision for income taxes is based on the following:

	For Three Months Ended
	March 31,
	2021			2020
Taxes calculated using the estimated annual effective tax rate	$	275		$	166
Discrete tax items	(89)			(116)
Provision for income taxes	$	186		$	50
Effective tax rate	10		%	4		%

4. Valuation of debt and equity investments and certain liabilities

Investments measured at fair value

Available-for-sale debt investments, money market funds and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. See Fair-value considerations below. Unrealized gains and losses from available-for-sale debt securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets and any credit losses on available-for-sale debt securities are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income.

Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A.

Other investments

Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results.

Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable equity investments are recognized in OI&E.

Details of our investments are as follows:

	March 31, 2021						December 31, 2020
	Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments		Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments
Measured at fair value:
Money market funds	$	1,236	$	—	$	—	$	886	$	—	$	—
Corporate obligations	253		1,069		—		256		407		—
U.S. government agency and Treasury securities	200		3,175		—		1,340		3,054		—
Mutual funds	—		—		14		—		—		18
Total	1,689		4,244		14		2,482		3,461		18
Other measurement basis:
Equity-method investments	—		—		52		—		—		27
Non-marketable equity investments	—		—		4		—		—		4
Cash on hand	753		—		—		625		—		—
Total	$	2,442	$	4,244	$	70	$	3,107	$	3,461	$	49

9

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

As of March 31, 2021, and December 31, 2020, unrealized gains and losses associated with our available-for-sale investments were not material. We did not recognize any credit losses related to available-for-sale investments for the first three months of 2021 and 2020.

Proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $2.00 billion and $1.39 billion for the first quarters of 2021 and 2020, respectively. Gross realized gains and losses from these sales were not material.

The following table presents the aggregate maturities of our available-for-sale debt investments as of March 31, 2021:

	Fair Value
One year or less	$	4,647
One to two years	50

During the first quarter of 2020, we entered into total return swaps to economically hedge the variability of certain deferred compensation obligations to employees. As a result, we received proceeds of $253 million from the sale of investments in mutual funds that were previously being utilized to offset this exposure.

Fair-value considerations

We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements.

•Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date.

•Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets.

•Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of March 31, 2021, and December 31, 2020, we had no Level 3 assets or liabilities.

10

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value.

	March 31, 2021						December 31, 2020
	Level 1		Level 2		Total		Level 1		Level 2		Total
Assets:
Money market funds	$	1,236	$	—	$	1,236	$	886	$	—	$	886
Corporate obligations	—		1,322		1,322		—		663		663
U.S. government agency and Treasury securities	3,325		50		3,375		4,394		—		4,394
Mutual funds	14		—		14		18		—		18
Total assets	$	4,575	$	1,372	$	5,947	$	5,298	$	663	$	5,961
Liabilities:
Deferred compensation	$	337	$	—	$	337	$	350	$	—	$	350
Total liabilities	$	337	$	—	$	337	$	350	$	—	$	350

5. Postretirement benefit plans

Expense related to defined benefit and retiree health care benefit plans is as follows:

	U.S. Defined Benefit				U.S. Retiree Health Care				Non-U.S. Defined Benefit
For Three Months Ended March 31,	2021		2020		2021		2020		2021		2020
Service cost	$	5	$	4	$	1	$	1	$	9	$	8
Interest cost	8		9		3		3		9		9
Expected return on plan assets	(8)		(9)		(3)		(3)		(20)		(18)
Recognized net actuarial loss	4		2		—		—		2		3
Net periodic benefit costs	9		6		1		1		—		2
Settlement losses	4		4		—		—		1		1
Total, including other postretirement losses	$	13	$	10	$	1	$	1	$	1	$	3

6. Debt and lines of credit

Short-term borrowings

We maintain a line of credit to support commercial paper borrowings, if any, and to provide additional liquidity through bank loans. As of March 31, 2021, we had a variable-rate revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to $2 billion until March 2024. The interest rate on borrowings under this credit facility, if drawn, is indexed to the applicable London Interbank Offered Rate (LIBOR). As of March 31, 2021, our credit facility was undrawn, and we had no commercial paper outstanding.

Long-term debt

In February 2021, we retired $550 million of maturing debt.

11

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Long-term debt outstanding is as follows:

	March 31,		December 31,
	2021		2020
Notes due 2021 at 2.75%	$	—	$	550
Notes due 2022 at 1.85%	500		500
Notes due 2023 at 2.25%	500		500
Notes due 2024 at 2.625%	300		300
Notes due 2025 at 1.375%	750		750
Notes due 2027 at 2.90%	500		500
Notes due 2029 at 2.25%	750		750
Notes due 2030 at 1.75%	750		750
Notes due 2039 at 3.875%	750		750
Notes due 2048 at 4.15%	1,500		1,500
Total debt	6,300		6,850
Net unamortized discounts, premiums and issuance costs	(50)		(52)
Total debt, including net unamortized discounts, premiums and issuance costs	6,250		6,798
Current portion of long-term debt	—		(550)
Long-term debt	$	6,250	$	6,248

Interest and debt expense was $46 million and $45 million for the first quarters of 2021 and 2020, respectively. This was net of the amortized discounts, premiums and issuance costs. Capitalized interest was not material.

7. Stockholders’ equity

Changes in equity are as follows:

	Common Stock		Paid-in Capital		Retained Earnings		Treasury Common Stock		AOCI
Balance, December 31, 2020	$	1,741	$	2,333	$	42,051	$	(36,578)	$	(360)
2021
Net income	—		—		1,753		—		—
Dividends declared and paid ($1.02 per share)	—		—		(940)		—		—
Common stock issued for stock-based awards	—		(3)		—		199		—
Stock repurchases	—		—		—		(100)		—
Stock compensation	—		61		—		—		—
Other comprehensive income (loss), net of taxes	—		—		—		—		13
Dividend equivalents on RSUs	—		—		(4)		—		—
Balance, March 31, 2021	$	1,741	$	2,391	$	42,860	$	(36,479)	$	(347)

12

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

	Common Stock		Paid-in Capital		Retained Earnings		Treasury Common Stock		AOCI
Balance, December 31, 2019	$	1,741	$	2,110	$	39,898	$	(34,495)	$	(347)
2020
Net income	—		—		1,174		—		—
Dividends declared and paid ($0.90 per share)	—		—		(841)		—		—
Common stock issued for stock-based awards	—		(77)		—		223		—
Stock repurchases	—		—		—		(1,730)		—
Stock compensation	—		63		—		—		—
Other comprehensive income (loss), net of taxes	—		—		—		—		19
Dividend equivalents on RSUs	—		—		(4)		—		—
Balance, March 31, 2020	$	1,741	$	2,096	$	40,227	$	(36,002)	$	(328)

8. Contingencies

Indemnification guarantees

We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.

Warranty costs/product liabilities

We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.

General

We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity.

9. Supplemental financial information

Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income

Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income during the first quarters of 2021 and 2020. The table below details where these transactions are recorded in our Consolidated Statements of Income.

	For Three Months Ended				Impact to Related Statement of Income Lines
	March 31,
	2021		2020
Net actuarial losses of defined benefit plans:
Recognized net actuarial loss and settlement losses (a)	$	11	$	10	Decrease to OI&E
Tax effect	(3)		(2)		Decrease to provision for income taxes
Recognized within net income, net of taxes	$	8	$	8	Decrease to net income

(a)Detailed in Note 5.

13

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Stock compensation

Total shares of 4,465,552 were issued from treasury shares during the first quarter of 2021 related to stock compensation.

14

ITEM 2. Management’s discussion and analysis of financial condition and results of operations

Overview

We design, make and sell semiconductors to electronics designers and manufacturers all over the world. Technology is the foundation of our company, but ultimately, our objective and the best metric to measure progress and generate long-term value for owners is the growth of free cash flow per share.

Our strategy to maximize free cash flow per share growth has three elements:

1.A great business model that is focused on analog and embedded processing products and built around four sustainable competitive advantages. The four sustainable competitive advantages are powerful in combination and provide tangible benefits:

i.A strong foundation of manufacturing and technology that provides lower costs and greater control of our supply chain.

ii.A broad portfolio of analog and embedded processing products that offers more opportunity per customer and more value for our investments.

iii.The reach of our market channels that gives access to more customers and more of their design projects, leading to the opportunity to sell more of our products into each design and gives us better insight and knowledge of customer needs.

iv.Diversity and longevity of our products, markets and customer positions that provide less single point dependency and longer returns on our investments.

Together, these competitive advantages help position TI in a unique class of companies capable of generating and returning significant amounts of cash for our owners. We make our investments with an eye towards long-term strengthening and leveraging of these advantages.

2.Discipline in allocating capital to the best opportunities. This spans how we select R&D projects, develop new capabilities like TI.com, invest in new manufacturing capacity or how we think about acquisitions and returning cash to our owners.

3.Efficiency, which means constantly striving for more output for every dollar spent.

We believe that our business model with the combined effect of our four competitive advantages sets TI apart from our peers and will for a long time to come. We will invest to strengthen our competitive advantages, be disciplined in capital allocation and stay diligent in our pursuit of efficiencies. Finally, we will remain focused on the belief that long-term growth of free cash flow per share is the ultimate measure to generate value.

Management’s discussion and analysis of financial condition and results of operations (MD&A) should be read in conjunction with the financial statements and the related notes that appear elsewhere in this document. In the following discussion of our results of operations:

•Our segments represent groups of similar products that are combined on the basis of similar design and development requirements, product characteristics, manufacturing processes and distribution channels, and how management allocates resources and measures results. See Note 1 to the financial statements for more information regarding our segments.

•When we discuss our results:

◦Unless otherwise noted, changes in our revenue are attributable to changes in customer demand, which are evidenced by fluctuations in shipment volumes.

◦New products do not tend to have a significant impact on our revenue in any given period because we sell such a large number of products.

◦From time to time, our revenue and gross profit are affected by changes in demand for higher-priced or lower-priced products, which we refer to as changes in the “mix” of products shipped.

15

◦Because we own much of our manufacturing capacity, a significant portion of our operating cost is fixed. When factory loadings decrease, our fixed costs are spread over reduced output and, absent other circumstances, our profit margins decrease. Conversely, as factory loadings increase, our fixed costs are spread over increased output and, absent other circumstances, our profit margins increase. Increases and decreases in factory loadings tend to correspond to increases and decreases in demand.

•For an explanation of free cash flow and the term “annual operating tax rate,” see the Non-GAAP financial information section.

•All dollar amounts in the tables are stated in millions of U.S. dollars.

The coronavirus (COVID-19) pandemic and its follow-on effects are impacting and will likely continue to impact business activity across industries worldwide, including TI. Therefore, we remain cautious about how the economy might behave for the next few years and continue to monitor potential impact on our operations.

Performance summary

Our first quarter revenue was $4.29 billion, net income was $1.75 billion and earnings per share (EPS) were $1.87.

Revenue increased 5% sequentially. In addition, revenue increased 29% from the same quarter a year ago due to strong demand in industrial, automotive and personal electronics.

In our core businesses, Analog revenue grew 5% and Embedded Processing grew 7% sequentially. From a year ago, Analog revenue grew 33% and Embedded Processing grew 17%.

Our cash flow from operations of $7.1 billion for the trailing 12 months again underscored the strength of our business model. Free cash flow for the same period was $6.3 billion and 41% of revenue. This reflects the quality of our product portfolio, as well as the efficiency of our manufacturing strategy, including the benefit of 300-millimeter Analog production.

We returned $4.5 billion to shareholders in the past 12 months through dividends and stock repurchases. Over the same period, our dividend represented 56% of free cash flow, underscoring its sustainability.

Results of operations – first quarter 2021 compared with first quarter 2020

Revenue of $4.29 billion increased $960 million, or 29%, due to higher revenue from Analog and, to a lesser extent, Embedded Processing.

Gross profit of $2.80 billion was up $709 million, or 34%, due to higher revenue. As a percentage of revenue, gross profit increased to 65.2% from 62.7%.

Operating expenses (R&D and SG&A) were $811 million compared with $794 million.

Acquisition charges were $47 million compared with $50 million and were non-cash.

Operating profit was $1.94 billion, or 45.2% of revenue, compared with $1.24 billion, or 37.4% of revenue.

OI&E was $46 million of income compared with $25 million of income.

Our provision for income taxes was $186 million compared with $50 million, which increased primarily due to higher income before income taxes. Our annual operating tax rate, which does not include discrete tax items, was 14% in both periods. We use “annual operating tax rate” to describe the estimated annual effective tax rate. The 2021 rate differs from the 21% U.S. statutory corporate tax rate due to the effect of U.S. tax benefits.

Net income was $1.75 billion compared with $1.17 billion. EPS was $1.87 compared with $1.24.

16

First quarter 2021 segment results

Our segment results compared with the year-ago quarter are as follows:

Analog (includes Power and Signal Chain product lines)

	Q1 2021			Q1 2020			Change
Revenue	$	3,280		$	2,460		33	%
Operating profit	1,646			1,025			61	%
Operating profit % of revenue	50.2		%	41.7		%

Analog revenue increased in both product lines about equally. Operating profit increased primarily due to higher revenue and associated gross profit.

Embedded Processing (includes microcontrollers and processors)

	Q1 2021			Q1 2020			Change
Revenue	$	767		$	653		17	%
Operating profit	287			182			58	%
Operating profit % of revenue	37.4		%	27.9		%

Embedded Processing revenue increased. Operating profit increased primarily due to higher revenue and associated gross profit.

Other (includes DLP® products, calculators and custom ASIC products)

	Q1 2021			Q1 2020			Change
Revenue	$	242		$	216		12	%
Operating profit*	6			37			(84)	%
Operating profit % of revenue	2.5		%	17.1		%
* Includes acquisition charges and restructuring charges/other

Other revenue increased $26 million. Operating profit decreased $31 million due to about $50 million of utility costs related to the February winter storm in Texas.

Financial condition

At the end of the first quarter of 2021, total cash (cash and cash equivalents plus short-term investments) was $6.69 billion, an increase of $118 million from the end of 2020.

Accounts receivable were $1.58 billion, an increase of $170 million compared with the end of 2020. Days sales outstanding at the end of the first quarter of 2021 were 33 compared with 31 at the end of 2020.

Inventory was $1.89 billion, a decrease of $65 million from the end of 2020. Days of inventory at the end of the first quarter of 2021 were 114 compared with 123 at the end of 2020.

Liquidity and capital resources

Our primary source of liquidity is cash flow from operations. Additional sources of liquidity are cash and cash equivalents, short-term investments and a variable-rate, revolving credit facility. Cash flows from operating activities for the first three months of 2021 were $1.85 billion, an increase of $999 million from the year-ago period due to higher net income and lower cash used for working capital.

Our revolving credit facility is with a consortium of investment-grade banks and allows us to borrow up to $2 billion until March 2024. This credit facility also serves as support for the issuance of commercial paper. As of March 31, 2021, our credit facility was undrawn, and we had no commercial paper outstanding.

17

Investing activities for the first three months of 2021 used $1.11 billion compared with providing cash of $826 million in the year-ago period. Capital expenditures were $308 million compared with $161 million in the year-ago period and were primarily for semiconductor manufacturing equipment and facilities in both periods. Short-term investments used cash of $782 million compared with providing cash of $992 million in the year-ago period.

Financing activities for the first three months of 2021 used $1.41 billion compared with $1.60 billion in the year-ago period. In 2021, we retired maturing debt of $550 million. In the year-ago period, we received net proceeds of $749 million from the issuance of fixed-rate, long-term debt. Dividends paid were $940 million compared with $841 million in the year-ago period, reflecting an increase in the dividend rate. We used $100 million to repurchase 0.6 million shares of our common stock compared with $1.64 billion used in the year-ago period to repurchase 14.9 million shares. Employee exercises of stock options provided cash proceeds of $196 million compared with $146 million in the year-ago period.

We had $2.44 billion of cash and cash equivalents and $4.24 billion of short-term investments as of March 31, 2021. We believe we have the necessary financial resources and operating plans to fund our working capital needs, capital expenditures, dividend and debt-related payments, and other business requirements for at least the next 12 months.

Non-GAAP financial information

This MD&A includes references to free cash flow and ratios based on that measure. These are financial measures that were not prepared in accordance with generally accepted accounting principles in the United States (GAAP). Free cash flow was calculated by subtracting capital expenditures from the most directly comparable GAAP measure, cash flows from operating activities (also referred to as cash flow from operations).

We believe that free cash flow and the associated ratios provide insight into our liquidity, our cash-generating capability and the amount of cash potentially available to return to shareholders, as well as insight into our financial performance. These non-GAAP measures are supplemental to the comparable GAAP measures.

Reconciliation to the most directly comparable GAAP measures is provided in the table below.

	For 12 Months Ended
	March 31,
	2021			2020			Change
Cash flow from operations (GAAP)	$	7,138		$	6,393		12	%
Capital expenditures	(796)			(757)
Free cash flow (non-GAAP)	$	6,342		$	5,636		13	%
Revenue	$	15,421		$	14,118
Cash flow from operations as a percentage of revenue (GAAP)	46.3		%	45.3		%
Free cash flow as a percentage of revenue (non-GAAP)	41.1		%	39.9		%

This MD&A also includes references to an annual operating tax rate, a non-GAAP term we use to describe the estimated annual effective tax rate, a GAAP measure that by definition does not include discrete tax items. We believe the term annual operating tax rate helps differentiate from the effective tax rate, which includes discrete tax items.

Long-term contractual obligations

Information regarding long-term contractual obligations is in Item 7 of our Form 10-K for the year ended December 31, 2020. Additionally, we retired $550 million of maturing debt during the first quarter of 2021.

18

ITEM 4. Controls and procedures

An evaluation as of the end of the period covered by this report was carried out under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that those disclosure controls and procedures were effective. In addition, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

19

PART II – OTHER INFORMATION

ITEM 1A. Risk factors

Information concerning our risk factors is contained in Item 1A of our Form 10-K for the year ended December 31, 2020, and is incorporated by reference herein.

ITEM 2. Unregistered sales of equity securities and use of proceeds

The following table contains information regarding our purchases of our common stock during the quarter.

ISSUER PURCHASES OF EQUITY SECURITIES

Period	Total Number of Shares Purchased		Average Price Paid per Share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (a)	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (a)
January 1, 2021 through January 31, 2021	—		$	—		—	$	10.63	billion
February 1, 2021 through February 28, 2021	584,953		170.20			304,186	10.58		billion
March 1, 2021 through March 31, 2021	272,678		172.35			272,678	10.53		billion
Total	857,631	(b)	$	170.88	(b)	576,864	$	10.53	billion (c)

(a)All open-market purchases during the quarter were made under the authorization from our board of directors to purchase up to $12.0 billion of additional shares of TI common stock announced September 20, 2018.

(b)In addition to open-market purchases, 280,767 shares of common stock were surrendered by employees to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

(c)As of March 31, 2021, this amount consisted of the remaining portion of the $12.0 billion authorized in September 2018. No expiration date has been specified for this authorization.

20

ITEM 6. Exhibits

Designation of Exhibits in This Report	Description of Exhibit
3(a)	Restated Certificate of Incorporation of the Registrant, dated April 18, 1985, as amended (incorporated by reference to Exhibit 3(a) of the Registrant's Annual Report on Form 10-K for the year ended December 31, 2014).
3(b)	By-Laws of the Registrant (incorporated by reference to Exhibit 3 of the Registrant's Current Report on Form 8-K filed July 16, 2020).
31(a)	Certification of Chief Executive Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
31(b)	Certification of Chief Financial Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
32(a)	Certification by Chief Executive Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
32(b)	Certification by Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
101.ins	XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.†
101.def	XBRL Taxonomy Extension Definition Linkbase Document.†
101.sch	XBRL Taxonomy Extension Schema Document.†
101.cal	XBRL Taxonomy Extension Calculation Linkbase Document.†
101.lab	XBRL Taxonomy Extension Label Linkbase Document.†
101.pre	XBRL Taxonomy Extension Presentation Linkbase Document.†
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).†
† Filed or furnished herewith.

21

Notice regarding forward-looking statements

This report includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as TI or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe TI’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

We urge you to carefully consider the following important factors that could cause actual results to differ materially from the expectations of TI or our management:

•The duration and scope of the COVID-19 pandemic, government and other third-party responses to it and the consequences for the global economy, including to our business and the businesses of our suppliers, customers and distributors;

•Economic, social and political conditions, and natural events in the countries in which we, our customers or our suppliers operate, including global trade policies;

•Market demand for semiconductors, particularly in the industrial and automotive markets, and customer demand that differs from forecasts;

•Our ability to compete in products and prices in an intensely competitive industry;

•Evolving cybersecurity and other threats relating to our information technology systems or those of our customers or suppliers;

•Our ability to successfully implement and realize opportunities from strategic, business and organizational changes, or our ability to realize our expectations regarding the amount and timing of associated restructuring charges and cost savings;

•Our ability to develop, manufacture and market innovative products in a rapidly changing technological environment, and our timely implementation of new manufacturing technologies and installation of manufacturing equipment;

•Availability and cost of raw materials, utilities, manufacturing equipment, third-party manufacturing services and manufacturing technology;

•Product liability, warranty or other claims relating to our products, manufacturing, delivery, services, design or communications, or recalls by our customers for a product containing one of our parts;

•Compliance with or changes in the complex laws, rules and regulations to which we are or may become subject, or actions of enforcement authorities, that restrict our ability to operate our business or subject us to fines, penalties or other legal liability;

•Changes in tax law and accounting standards that impact the tax rate applicable to us, the jurisdictions in which profits are determined to be earned and taxed, adverse resolution of tax audits, increases in tariff rates, and the ability to realize deferred tax assets;

•A loss suffered by one of our customers or distributors with respect to TI-consigned inventory;

•Financial difficulties of our distributors or semiconductor distributors’ promotion of competing product lines to our detriment; or disputes with current or former distributors;

•Losses or curtailments of purchases from key customers or the timing and amount of distributor and other customer inventory adjustments;

•Our ability to maintain or improve profit margins, including our ability to utilize our manufacturing facilities at sufficient levels to cover our fixed operating costs, in an intensely competitive and cyclical industry and changing regulatory environment;

•Our ability to maintain and enforce a strong intellectual property portfolio and maintain freedom of operation in all jurisdictions where we conduct business; or our exposure to infringement claims;

•Instability in the global credit and financial markets;

•Increases in health care and pension benefit costs;

•Our ability to recruit and retain skilled personnel, and effectively manage key employee succession; and

22

•Impairments of our non-financial assets.

For a more detailed discussion of these factors, see the Risk factors discussion in Item 1A of our most recent Form 10-K. The forward-looking statements included in this report are made only as of the date of this report, and we undertake no obligation to update the forward-looking statements to reflect subsequent events or circumstances. If we do update any forward-looking statement, you should not infer that we will make additional updates with respect to that statement or any other forward-looking statement.

23

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TEXAS INSTRUMENTS INCORPORATED
By:	/s/	Rafael R. Lizardi
		Rafael R. Lizardi
		Senior Vice President and
		Chief Financial Officer

Date: April 28, 2021

EX-31.A

Exhibit 31(a)

CERTIFICATIONS

I, Richard K. Templeton, certify that:

1.I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: April 28, 2021

/s/ Richard K. Templeton

Richard K. Templeton
Chairman, President
and Chief Executive Officer

EX-31.B

Exhibit 31(b)

CERTIFICATIONS

I, Rafael R. Lizardi, certify that:

1.I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: April 28, 2021

/s/ Rafael R. Lizardi

Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

EX-32.A

Exhibit 32(a)

Certification of Periodic Report

Pursuant to 18 U.S.C. Section 1350

For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Richard K. Templeton, the Chairman, President and Chief Executive Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that, to his knowledge:

(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:  April 28, 2021

/s/ Richard K. Templeton

Richard K. Templeton
Chairman, President
and Chief Executive Officer

EX-32.B

Exhibit 32(b)

Certification of Periodic Report

Pursuant to 18 U.S.C. Section 1350

For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Rafael R. Lizardi, Senior Vice President and Chief Financial Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that, to his knowledge:

(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: April 28, 2021

/s/ Rafael R. Lizardi

Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

XML

Cover Page - shares	3 Months Ended
	Mar. 31, 2021	Apr. 20, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	001-03761
Entity Registrant Name	TEXAS INSTRUMENTS INCORPORATED
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-0289970
Entity Address, Address Line One	12500 TI Boulevard
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75243
City Area Code	214
Local Phone Number	479-3773
Title of 12(b) Security	Common Stock, par value $1.00
Trading Symbol	TXN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		923,523,523
Entity Central Index Key	0000097476
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenue	$ 4,289	$ 3,329
Cost of revenue (COR)	1,492	1,241
Gross profit	2,797	2,088
Research and development (R&D)	386	377
Selling, general and administrative (SG&A)	425	417
Acquisition charges	47	50
Operating profit	1,939	1,244
Other income (expense), net (OI&E)	46	25
Interest and debt expense	46	45
Income before income taxes	1,939	1,224
Provision for income taxes	186	50
Net income	$ 1,753	$ 1,174
Earnings per common share (EPS):
Basic (in dollars per share)	$ 1.89	$ 1.25
Diluted (in dollars per share)	$ 1.87	$ 1.24
Average shares outstanding (millions):
Basic (in shares)	922	931
Diluted (in shares)	935	943
Diluted EPS:
Net income	$ 1,753	$ 1,174
Income allocated to RSUs	(8)	(6)
Income allocated to common stock for diluted EPS	$ 1,745	$ 1,168

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 1,753	$ 1,174
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($2) and ($3)	5	9
Recognized within net income, net of tax effect of ($3) and ($2)	8	8
Available-for-sale investments:
Unrealized gains, net of tax effect of $0 and $0	0	2
Other comprehensive income (loss), net of taxes	13	19
Total comprehensive income	$ 1,766	$ 1,193

XML

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Net actuarial losses of defined benefit plans adjustment, tax effect	$ (2)	$ (3)
Net actuarial losses of defined benefit plans recognized within net income, tax effect	(3)	(2)
Available-for-sale investments unrealized losses, tax effect	$ 0	$ 0

XML

Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 2,442	$ 3,107
Short-term investments	4,244	3,461
Accounts receivable, net of allowances of ($9) and ($11)	1,584	1,414
Raw materials	183	180
Work in process	980	964
Finished goods	727	811
Inventories	1,890	1,955
Prepaid expenses and other current assets	245	302
Total current assets	10,405	10,239
Property, plant and equipment at cost	5,967	5,781
Accumulated depreciation	(2,536)	(2,512)
Property, plant and equipment	3,431	3,269
Goodwill	4,362	4,362
Acquisition-related intangibles	105	152
Deferred tax assets	331	343
Capitalized software licenses	113	122
Overfunded retirement plans	235	246
Other long-term assets	657	618
Total assets	19,639	19,351
Current liabilities:
Current portion of long-term debt	0	550
Accounts payable	567	415
Accrued compensation	388	767
Income taxes payable	278	134
Accrued expenses and other liabilities	467	524
Total current liabilities	1,700	2,390
Long-term debt	6,250	6,248
Underfunded retirement plans	130	131
Deferred tax liabilities	88	90
Other long-term liabilities	1,305	1,305
Total liabilities	9,473	10,164
Stockholders’ equity:
Preferred stock, $25 par value. Authorized – 10,000,000 shares Participating cumulative preferred – None issued	0	0
Common stock, $1 par value. Authorized - 2,400,000,000 shares, Shares issued - 1,740,815,939	1,741	1,741
Paid-in capital	2,391	2,333
Retained earnings	42,860	42,051
Treasury common stock at cost: Shares: March 31, 2021 – 817,573,099; December 31, 2020 – 821,461,787	(36,479)	(36,578)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(347)	(360)
Total stockholders’ equity	10,166	9,187
Total liabilities and stockholders’ equity	$ 19,639	$ 19,351

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Allowance for doubtful accounts receivable, current	$ 9	$ 11
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 25	$ 25
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	2,400,000,000	2,400,000,000
Common stock, shares issued (in shares)	1,740,815,939	1,740,815,939
Treasury stock (in shares)	817,573,099	821,461,787

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net income	$ 1,753	$ 1,174
Adjustments to net income:
Depreciation	179	186
Amortization of acquisition-related intangibles	47	50
Amortization of capitalized software	15	14
Stock compensation	61	63
Gains on sales of assets	(1)	0
Deferred taxes	8	(34)
Increase (decrease) from changes in:
Accounts receivable	(170)	(242)
Inventories	65	(2)
Prepaid expenses and other current assets	73	(88)
Accounts payable and accrued expenses	69	0
Accrued compensation	(379)	(353)
Income taxes payable	131	147
Changes in funded status of retirement plans	28	27
Other	(29)	(91)
Cash flows from operating activities	1,850	851
Cash flows from investing activities
Capital expenditures	(308)	(161)
Proceeds from asset sales	1	0
Purchases of short-term investments	(2,782)	(646)
Proceeds from short-term investments	2,000	1,638
Other	(20)	(5)
Cash flows from investing activities	(1,109)	826
Cash flows from financing activities
Proceeds from issuance of long-term debt	0	749
Repayment of debt	(550)	0
Dividends paid	(940)	(841)
Stock repurchases	(100)	(1,641)
Proceeds from common stock transactions	196	146
Other	(12)	(9)
Cash flows from financing activities	(1,406)	(1,596)
Net change in cash and cash equivalents	(665)	81
Cash and cash equivalents at beginning of period	3,107	2,437
Cash and cash equivalents at end of period	$ 2,442	$ 2,518

XML

Description of business, including segment and geographic area information

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Description of business, including segment and geographic area information

Description of business, including segment and geographic area information

We design, make and sell semiconductors to electronics designers and manufacturers all over the world. We have two reportable segments, Analog and Embedded Processing, each of which represents groups of similar products that are combined on the basis of similar design and development requirements, product characteristics, manufacturing processes and distribution channels.

•Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing, discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog segment consists of two major product lines: Power and Signal Chain.

•Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific tasks and can be optimized for various combinations of performance, power and cost, depending on the application.

We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP® products, calculators and custom ASIC products.

Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not provided.

Segment information

	For Three Months Ended
	March 31,
	2021		2020
Revenue:
Analog	$	3,280	$	2,460
Embedded Processing	767		653
Other	242		216
Total revenue	$	4,289	$	3,329
Operating profit:
Analog	$	1,646	$	1,025
Embedded Processing	287		182
Other (a)	6		37
Total operating profit	$	1,939	$	1,244

(a)Includes acquisition charges and restructuring charges/other

Geographic area information

The following geographic area information includes revenue, based on product shipment destination. The geographic revenue information does not necessarily reflect end demand by geography because our products tend to be shipped to the locations where our customers manufacture their products.

	For Three Months Ended
	March 31,
	2021		2020
Revenue:
United States	$	393	$	390
Asia (a)	2,858		2,027
Europe, Middle East and Africa	682		619
Japan	239		190
Rest of world	117		103
Total revenue	$	4,289	$	3,329

(a)Revenue from products shipped into China was $2.3 billion and $1.7 billion in the first quarters of 2021 and 2020, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

XML

Basis of presentation and significant accounting policies and practices

3 Months Ended

Mar. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of presentation and significant accounting policies and practices

Basis of presentation and significant accounting policies and practices

Basis of presentation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2020. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended March 31, 2021 and 2020, and the Consolidated Balance Sheet as of March 31, 2021, are not audited but reflect all adjustments that are of a normal recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2020. The results for the three-month periods are not necessarily indicative of a full year’s results.

Significant accounting policies and practices

Earnings per share (EPS)

We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock.

Computation and reconciliation of earnings per common share are as follows (shares in millions):

	For Three Months Ended March 31,
	2021					2020
	Net Income		Shares	EPS		Net Income		Shares	EPS
Basic EPS:
Net income	$	1,753				$	1,174
Income allocated to RSUs	(8)					(6)
Income allocated to common stock	$	1,745	922	$	1.89	$	1,168	931	$	1.25
Dilutive effect of stock compensation plans			13					12
Diluted EPS:
Net income	$	1,753				$	1,174
Income allocated to RSUs	(8)					(6)
Income allocated to common stock	$	1,745	935	$	1.87	$	1,168	943	$	1.24

Potentially dilutive securities representing 3 million and 9 million shares of common stock that were outstanding during the first quarters of 2021 and 2020, respectively, were excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-dilutive.

Derivatives and hedging

We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments.

We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A.

In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material.

We do not use derivatives for speculative or trading purposes.

Fair values of financial instruments

The fair values of our derivative financial instruments were not material as of March 31, 2021. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of March 31, 2021, the carrying value of long-term debt, including the current portion, was $6.25 billion, and the estimated fair value was $6.74 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.

XML

Income taxes

3 Months Ended

Mar. 31, 2021

Income Tax Disclosure [Abstract]

Income taxes

Income taxesOur estimated annual effective tax rate is about 14%, which does not include discrete tax items. This differs from the 21% U.S. statutory corporate tax rate due to the effect of U.S. tax benefits.

Provision for income taxes is based on the following:

	For Three Months Ended
	March 31,
	2021			2020
Taxes calculated using the estimated annual effective tax rate	$	275		$	166
Discrete tax items	(89)			(116)
Provision for income taxes	$	186		$	50
Effective tax rate	10		%	4		%

XML

Valuation of debt and equity investments and certain liabilities

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Valuation of debt and equity investments and certain liabilities

Valuation of debt and equity investments and certain liabilities

Investments measured at fair value

Available-for-sale debt investments, money market funds and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. See Fair-value considerations below. Unrealized gains and losses from available-for-sale debt securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets and any credit losses on available-for-sale debt securities are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income.

Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A.

Other investments

Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results.

Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable equity investments are recognized in OI&E.

Details of our investments are as follows:

	March 31, 2021						December 31, 2020
	Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments		Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments
Measured at fair value:
Money market funds	$	1,236	$	—	$	—	$	886	$	—	$	—
Corporate obligations	253		1,069		—		256		407		—
U.S. government agency and Treasury securities	200		3,175		—		1,340		3,054		—
Mutual funds	—		—		14		—		—		18
Total	1,689		4,244		14		2,482		3,461		18
Other measurement basis:
Equity-method investments	—		—		52		—		—		27
Non-marketable equity investments	—		—		4		—		—		4
Cash on hand	753		—		—		625		—		—
Total	$	2,442	$	4,244	$	70	$	3,107	$	3,461	$	49

As of March 31, 2021, and December 31, 2020, unrealized gains and losses associated with our available-for-sale investments were not material. We did not recognize any credit losses related to available-for-sale investments for the first three months of 2021 and 2020.

Proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $2.00 billion and $1.39 billion for the first quarters of 2021 and 2020, respectively. Gross realized gains and losses from these sales were not material.

The following table presents the aggregate maturities of our available-for-sale debt investments as of March 31, 2021:

	Fair Value
One year or less	$	4,647
One to two years	50

During the first quarter of 2020, we entered into total return swaps to economically hedge the variability of certain deferred compensation obligations to employees. As a result, we received proceeds of $253 million from the sale of investments in mutual funds that were previously being utilized to offset this exposure.

Fair-value considerations

We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements.

•Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date.

•Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets.

•Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of March 31, 2021, and December 31, 2020, we had no Level 3 assets or liabilities.

The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value.

	March 31, 2021						December 31, 2020
	Level 1		Level 2		Total		Level 1		Level 2		Total
Assets:
Money market funds	$	1,236	$	—	$	1,236	$	886	$	—	$	886
Corporate obligations	—		1,322		1,322		—		663		663
U.S. government agency and Treasury securities	3,325		50		3,375		4,394		—		4,394
Mutual funds	14		—		14		18		—		18
Total assets	$	4,575	$	1,372	$	5,947	$	5,298	$	663	$	5,961
Liabilities:
Deferred compensation	$	337	$	—	$	337	$	350	$	—	$	350
Total liabilities	$	337	$	—	$	337	$	350	$	—	$	350

XML

Postretirement benefit plans

3 Months Ended

Mar. 31, 2021

Retirement Benefits [Abstract]

Postretirement benefit plans

Postretirement benefit plans

Expense related to defined benefit and retiree health care benefit plans is as follows:

	U.S. Defined Benefit				U.S. Retiree Health Care				Non-U.S. Defined Benefit
For Three Months Ended March 31,	2021		2020		2021		2020		2021		2020
Service cost	$	5	$	4	$	1	$	1	$	9	$	8
Interest cost	8		9		3		3		9		9
Expected return on plan assets	(8)		(9)		(3)		(3)		(20)		(18)
Recognized net actuarial loss	4		2		—		—		2		3
Net periodic benefit costs	9		6		1		1		—		2
Settlement losses	4		4		—		—		1		1
Total, including other postretirement losses	$	13	$	10	$	1	$	1	$	1	$	3

XML

Debt and lines of credit

3 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Debt and lines of credit

Debt and lines of credit

Short-term borrowings

We maintain a line of credit to support commercial paper borrowings, if any, and to provide additional liquidity through bank loans. As of March 31, 2021, we had a variable-rate revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to $2 billion until March 2024. The interest rate on borrowings under this credit facility, if drawn, is indexed to the applicable London Interbank Offered Rate (LIBOR). As of March 31, 2021, our credit facility was undrawn, and we had no commercial paper outstanding.

Long-term debt

In February 2021, we retired $550 million of maturing debt.

Long-term debt outstanding is as follows:

	March 31,		December 31,
	2021		2020
Notes due 2021 at 2.75%	$	—	$	550
Notes due 2022 at 1.85%	500		500
Notes due 2023 at 2.25%	500		500
Notes due 2024 at 2.625%	300		300
Notes due 2025 at 1.375%	750		750
Notes due 2027 at 2.90%	500		500
Notes due 2029 at 2.25%	750		750
Notes due 2030 at 1.75%	750		750
Notes due 2039 at 3.875%	750		750
Notes due 2048 at 4.15%	1,500		1,500
Total debt	6,300		6,850
Net unamortized discounts, premiums and issuance costs	(50)		(52)
Total debt, including net unamortized discounts, premiums and issuance costs	6,250		6,798
Current portion of long-term debt	—		(550)
Long-term debt	$	6,250	$	6,248

Interest and debt expense was $46 million and $45 million for the first quarters of 2021 and 2020, respectively. This was net of the amortized discounts, premiums and issuance costs. Capitalized interest was not material.

XML

Stockholders' equity

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Stockholders’ equity

Stockholders’ equity

Changes in equity are as follows:

	Common Stock		Paid-in Capital		Retained Earnings		Treasury Common Stock		AOCI
Balance, December 31, 2020	$	1,741	$	2,333	$	42,051	$	(36,578)	$	(360)
2021
Net income	—		—		1,753		—		—
Dividends declared and paid ($1.02 per share)	—		—		(940)		—		—
Common stock issued for stock-based awards	—		(3)		—		199		—
Stock repurchases	—		—		—		(100)		—
Stock compensation	—		61		—		—		—
Other comprehensive income (loss), net of taxes	—		—		—		—		13
Dividend equivalents on RSUs	—		—		(4)		—		—
Balance, March 31, 2021	$	1,741	$	2,391	$	42,860	$	(36,479)	$	(347)

	Common Stock		Paid-in Capital		Retained Earnings		Treasury Common Stock		AOCI
Balance, December 31, 2019	$	1,741	$	2,110	$	39,898	$	(34,495)	$	(347)
2020
Net income	—		—		1,174		—		—
Dividends declared and paid ($0.90 per share)	—		—		(841)		—		—
Common stock issued for stock-based awards	—		(77)		—		223		—
Stock repurchases	—		—		—		(1,730)		—
Stock compensation	—		63		—		—		—
Other comprehensive income (loss), net of taxes	—		—		—		—		19
Dividend equivalents on RSUs	—		—		(4)		—		—
Balance, March 31, 2020	$	1,741	$	2,096	$	40,227	$	(36,002)	$	(328)

XML

Contingencies

3 Months Ended

Mar. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Contingencies

Contingencies

Indemnification guarantees

We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.

Warranty costs/product liabilities

We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.

General

We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity.

XML

Supplemental financial information

3 Months Ended

Mar. 31, 2021

Supplemental Financial Information [Abstract]

Supplemental financial information

Supplemental financial information

Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income

Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income during the first quarters of 2021 and 2020. The table below details where these transactions are recorded in our Consolidated Statements of Income.

	For Three Months Ended				Impact to Related Statement of Income Lines
	March 31,
	2021		2020
Net actuarial losses of defined benefit plans:
Recognized net actuarial loss and settlement losses (a)	$	11	$	10	Decrease to OI&E
Tax effect	(3)		(2)		Decrease to provision for income taxes
Recognized within net income, net of taxes	$	8	$	8	Decrease to net income

(a)Detailed in Note 5.

Stock compensationTotal shares of 4,465,552 were issued from treasury shares during the first quarter of 2021 related to stock compensation.

XML

Basis of presentation and significant accounting policies and practices (Policies)

3 Months Ended

Mar. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of presentation

Basis of presentation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2020. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended March 31, 2021 and 2020, and the Consolidated Balance Sheet as of March 31, 2021, are not audited but reflect all adjustments that are of a normal recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2020. The results for the three-month periods are not necessarily indicative of a full year’s results.

Earnings per share (EPS)

Earnings per share (EPS)

We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock.

Derivatives and hedging

Derivatives and hedging

We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments.

We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A.

In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material.

We do not use derivatives for speculative or trading purposes.

Fair values of financial instruments

Fair values of financial instruments

The fair values of our derivative financial instruments were not material as of March 31, 2021. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of March 31, 2021, the carrying value of long-term debt, including the current portion, was $6.25 billion, and the estimated fair value was $6.74 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.

Investments measured at fair value

Investments measured at fair value

Available-for-sale debt investments, money market funds and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. See Fair-value considerations below. Unrealized gains and losses from available-for-sale debt securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets and any credit losses on available-for-sale debt securities are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income.

Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A.

Other investments

Our other investments include equity-method investments and non-marketable equity investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results.

Non-marketable equity securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable equity investments are recognized in OI&E.

Fair value considerations

Fair-value considerations

We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements.

•Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date.

•Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets.

•Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of March 31, 2021, and December 31, 2020, we had no Level 3 assets or liabilities.

Indemnification guarantees and warranty costs/product liabilities

Indemnification guarantees

We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.

Warranty costs/product liabilities

We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.

XML

Description of business, including segment and geographic area information (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Schedule of Segment Information

	For Three Months Ended
	March 31,
	2021		2020
Revenue:
Analog	$	3,280	$	2,460
Embedded Processing	767		653
Other	242		216
Total revenue	$	4,289	$	3,329
Operating profit:
Analog	$	1,646	$	1,025
Embedded Processing	287		182
Other (a)	6		37
Total operating profit	$	1,939	$	1,244

(a)Includes acquisition charges and restructuring charges/other

Schedule of Geographic Area Information

Geographic area information

The following geographic area information includes revenue, based on product shipment destination. The geographic revenue information does not necessarily reflect end demand by geography because our products tend to be shipped to the locations where our customers manufacture their products.

	For Three Months Ended
	March 31,
	2021		2020
Revenue:
United States	$	393	$	390
Asia (a)	2,858		2,027
Europe, Middle East and Africa	682		619
Japan	239		190
Rest of world	117		103
Total revenue	$	4,289	$	3,329

(a)Revenue from products shipped into China was $2.3 billion and $1.7 billion in the first quarters of 2021 and 2020, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

XML

Basis of presentation and significant accounting policies and practices (Tables)

3 Months Ended

Mar. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Earnings Per Share

Computation and reconciliation of earnings per common share are as follows (shares in millions):

	For Three Months Ended March 31,
	2021					2020
	Net Income		Shares	EPS		Net Income		Shares	EPS
Basic EPS:
Net income	$	1,753				$	1,174
Income allocated to RSUs	(8)					(6)
Income allocated to common stock	$	1,745	922	$	1.89	$	1,168	931	$	1.25
Dilutive effect of stock compensation plans			13					12
Diluted EPS:
Net income	$	1,753				$	1,174
Income allocated to RSUs	(8)					(6)
Income allocated to common stock	$	1,745	935	$	1.87	$	1,168	943	$	1.24

XML

Income taxes (Tables)

3 Months Ended

Mar. 31, 2021

Income Tax Disclosure [Abstract]

Provision for income taxes

Provision for income taxes is based on the following:

	For Three Months Ended
	March 31,
	2021			2020
Taxes calculated using the estimated annual effective tax rate	$	275		$	166
Discrete tax items	(89)			(116)
Provision for income taxes	$	186		$	50
Effective tax rate	10		%	4		%

XML

Valuation of debt and equity investments and certain liabilities (Tables)

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Investments

Details of our investments are as follows:

	March 31, 2021						December 31, 2020
	Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments		Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments
Measured at fair value:
Money market funds	$	1,236	$	—	$	—	$	886	$	—	$	—
Corporate obligations	253		1,069		—		256		407		—
U.S. government agency and Treasury securities	200		3,175		—		1,340		3,054		—
Mutual funds	—		—		14		—		—		18
Total	1,689		4,244		14		2,482		3,461		18
Other measurement basis:
Equity-method investments	—		—		52		—		—		27
Non-marketable equity investments	—		—		4		—		—		4
Cash on hand	753		—		—		625		—		—
Total	$	2,442	$	4,244	$	70	$	3,107	$	3,461	$	49

Assets and Liabilities Accounted for at Fair Value

The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value.

	March 31, 2021						December 31, 2020
	Level 1		Level 2		Total		Level 1		Level 2		Total
Assets:
Money market funds	$	1,236	$	—	$	1,236	$	886	$	—	$	886
Corporate obligations	—		1,322		1,322		—		663		663
U.S. government agency and Treasury securities	3,325		50		3,375		4,394		—		4,394
Mutual funds	14		—		14		18		—		18
Total assets	$	4,575	$	1,372	$	5,947	$	5,298	$	663	$	5,961
Liabilities:
Deferred compensation	$	337	$	—	$	337	$	350	$	—	$	350
Total liabilities	$	337	$	—	$	337	$	350	$	—	$	350

Aggregate Maturities of Available-for-sale Debt Investments

The following table presents the aggregate maturities of our available-for-sale debt investments as of March 31, 2021:

	Fair Value
One year or less	$	4,647
One to two years	50

XML

Postretirement benefit plans (Tables)

3 Months Ended

Mar. 31, 2021

Retirement Benefits [Abstract]

Expense Related to Defined Benefit and Retiree Health Care Benefit Plans

Expense related to defined benefit and retiree health care benefit plans is as follows:

	U.S. Defined Benefit				U.S. Retiree Health Care				Non-U.S. Defined Benefit
For Three Months Ended March 31,	2021		2020		2021		2020		2021		2020
Service cost	$	5	$	4	$	1	$	1	$	9	$	8
Interest cost	8		9		3		3		9		9
Expected return on plan assets	(8)		(9)		(3)		(3)		(20)		(18)
Recognized net actuarial loss	4		2		—		—		2		3
Net periodic benefit costs	9		6		1		1		—		2
Settlement losses	4		4		—		—		1		1
Total, including other postretirement losses	$	13	$	10	$	1	$	1	$	1	$	3

XML

Debt and lines of credit (Tables)

3 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments

Long-term debt outstanding is as follows:

	March 31,		December 31,
	2021		2020
Notes due 2021 at 2.75%	$	—	$	550
Notes due 2022 at 1.85%	500		500
Notes due 2023 at 2.25%	500		500
Notes due 2024 at 2.625%	300		300
Notes due 2025 at 1.375%	750		750
Notes due 2027 at 2.90%	500		500
Notes due 2029 at 2.25%	750		750
Notes due 2030 at 1.75%	750		750
Notes due 2039 at 3.875%	750		750
Notes due 2048 at 4.15%	1,500		1,500
Total debt	6,300		6,850
Net unamortized discounts, premiums and issuance costs	(50)		(52)
Total debt, including net unamortized discounts, premiums and issuance costs	6,250		6,798
Current portion of long-term debt	—		(550)
Long-term debt	$	6,250	$	6,248

XML

Stockholders' equity (Tables)

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Schedule of Changes in Stockholders' Equity

Changes in equity are as follows:

	Common Stock		Paid-in Capital		Retained Earnings		Treasury Common Stock		AOCI
Balance, December 31, 2020	$	1,741	$	2,333	$	42,051	$	(36,578)	$	(360)
2021
Net income	—		—		1,753		—		—
Dividends declared and paid ($1.02 per share)	—		—		(940)		—		—
Common stock issued for stock-based awards	—		(3)		—		199		—
Stock repurchases	—		—		—		(100)		—
Stock compensation	—		61		—		—		—
Other comprehensive income (loss), net of taxes	—		—		—		—		13
Dividend equivalents on RSUs	—		—		(4)		—		—
Balance, March 31, 2021	$	1,741	$	2,391	$	42,860	$	(36,479)	$	(347)

	Common Stock		Paid-in Capital		Retained Earnings		Treasury Common Stock		AOCI
Balance, December 31, 2019	$	1,741	$	2,110	$	39,898	$	(34,495)	$	(347)
2020
Net income	—		—		1,174		—		—
Dividends declared and paid ($0.90 per share)	—		—		(841)		—		—
Common stock issued for stock-based awards	—		(77)		—		223		—
Stock repurchases	—		—		—		(1,730)		—
Stock compensation	—		63		—		—		—
Other comprehensive income (loss), net of taxes	—		—		—		—		19
Dividend equivalents on RSUs	—		—		(4)		—		—
Balance, March 31, 2020	$	1,741	$	2,096	$	40,227	$	(36,002)	$	(328)

XML

Supplemental financial information (Tables)

3 Months Ended

Mar. 31, 2021

Supplemental Financial Information [Abstract]

Amounts Reclassified Out of AOCI to Net Income, Net of Taxes

The table below details where these transactions are recorded in our Consolidated Statements of Income.

	For Three Months Ended				Impact to Related Statement of Income Lines
	March 31,
	2021		2020
Net actuarial losses of defined benefit plans:
Recognized net actuarial loss and settlement losses (a)	$	11	$	10	Decrease to OI&E
Tax effect	(3)		(2)		Decrease to provision for income taxes
Recognized within net income, net of taxes	$	8	$	8	Decrease to net income

(a)Detailed in Note 5.

XML

Description of business, including segment and geographic area information - Additional Information (Details)	3 Months Ended
	Mar. 31, 2021 reportable_segment
Segment Reporting [Abstract]
Number of reportable segments	2

XML

Description of business, including segment and geographic area information - Segment Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Segment Reporting Information [Line Items]
Total revenue	$ 4,289	$ 3,329
Total operating profit	1,939	1,244
Analog
Segment Reporting Information [Line Items]
Total revenue	3,280	2,460
Total operating profit	1,646	1,025
Embedded Processing
Segment Reporting Information [Line Items]
Total revenue	767	653
Total operating profit	287	182
Other
Segment Reporting Information [Line Items]
Total revenue	242	216
Total operating profit	$ 6	$ 37

XML

Description of business, including segment and geographic area information - Geographic Area Information (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2021	Mar. 31, 2020
Segment Reporting Information [Line Items]
Total revenue		$ 4,289	$ 3,329
United States
Segment Reporting Information [Line Items]
Total revenue		393	390
Asia
Segment Reporting Information [Line Items]
Total revenue	[1]	2,858	2,027
Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Total revenue		682	619
Japan
Segment Reporting Information [Line Items]
Total revenue		239	190
Rest of world
Segment Reporting Information [Line Items]
Total revenue		117	103
China
Segment Reporting Information [Line Items]
Total revenue		$ 2,300	$ 1,700

[1] Revenue from products shipped into China was $2.3 billion and $1.7 billion in the first quarters of 2021 and 2020, respectively, which includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.

XML

Basis of presentation and significant accounting policies and practices - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Basic EPS:
Net income	$ 1,753	$ 1,174
Income allocated to RSUs	(8)	(6)
Income allocated to common stock for basic EPS	$ 1,745	$ 1,168
Weighted average number of shares outstanding, basic (in shares)	922	931
Basic (in dollars per share)	$ 1.89	$ 1.25
Dilutive effect of stock compensation plans (in shares)	13	12
Diluted EPS:
Net income	$ 1,753	$ 1,174
Income allocated to RSUs	(8)	(6)
Income allocated to common stock for diluted EPS	$ 1,745	$ 1,168
Weighted average number of shares outstanding, diluted (in shares)	935	943
Diluted (in dollars per share)	$ 1.87	$ 1.24

XML

Basis of presentation and significant accounting policies and practices - Additional Information (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Antidilutive securities excluded from computation of earnings per share, Amount (in shares)	3	9
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, carrying value	$ 6,250		$ 6,798
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, estimated fair value	$ 6,740

XML

Income taxes - Additional Information (Details)	3 Months Ended
	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Estimated annual effective tax rate	14.00%
Statutory corporate tax rate	21.00%

XML

Income taxes - Provision for Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Taxes calculated using the estimated annual effective tax rate	$ 275	$ 166
Discrete tax items	(89)	(116)
Provision for income taxes	$ 186	$ 50
Effective tax rate	10.00%	4.00%

XML

Valuation of debt and equity investments and certain liabilities - Investments at Fair Value (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	$ 2,442	$ 3,107
Short-Term Investments	4,244	3,461
Long-Term Investments	70	49
Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,689	2,482
Short-Term Investments	4,244	3,461
Long-Term Investments	14	18
Measured at fair value | Available-for-sale debt securities | Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,236	886
Short-Term Investments	0	0
Long-Term Investments	0	0
Measured at fair value | Available-for-sale debt securities | Corporate obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	253	256
Short-Term Investments	1,069	407
Long-Term Investments	0	0
Measured at fair value | Available-for-sale debt securities | U.S. government agency and Treasury securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	200	1,340
Short-Term Investments	3,175	3,054
Long-Term Investments	0	0
Measured at fair value | Trading securities | Mutual funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	14	18
Other measurement basis | Equity-method investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	52	27
Other measurement basis | Non-marketable equity investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	4	4
Other measurement basis | Cash on hand
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	753	625
Short-Term Investments	0	0
Long-Term Investments	$ 0	$ 0

XML

Valuation of debt and equity investments and certain liabilities - Aggregate Liabilities of Our Available-for-Sale Debt Investments (Details) $ in Millions	Mar. 31, 2021 USD ($)
Fair Value Disclosures [Abstract]
One year or less	$ 4,647
One to two years	$ 50

XML

Valuation of debt and equity investments and certain liabilities - Fair Value Assets and Liabilities Measured on Recurring Basis (Details) - Recurring - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	$ 5,947	$ 5,961
Total liabilities fair value	337	350
Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	337	350
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	4,575	5,298
Total liabilities fair value	337	350
Level 1 | Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	337	350
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,372	663
Total liabilities fair value	0	0
Level 2 | Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,236	886
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,236	886
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Corporate obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,322	663
Corporate obligations | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Corporate obligations | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,322	663
U.S. government agency and Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	3,375	4,394
U.S. government agency and Treasury securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	3,325	4,394
U.S. government agency and Treasury securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	50	0
Mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	14	18
Mutual funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	14	18
Mutual funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	$ 0	$ 0

XML

Valuation of debt and equity investments and certain liabilities - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Credit losses related to available-for-sale investments	$ 0	$ 0
Proceeds from sales, redemptions and maturities of short-term available-for-sale investments	2,000,000,000.00	1,390,000,000
Proceeds from sale of short-term investments		$ 253,000,000
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities, fair value	0		$ 0
Assets, fair value	$ 0		$ 0

XML

Postretirement benefit plans - Expense Related to Defined Benefit and Retiree Health Care Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
U.S. | Defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 5	$ 4
Interest cost	8	9
Expected return on plan assets	(8)	(9)
Recognized net actuarial loss	4	2
Net periodic benefit costs	9	6
Settlement losses	4	4
Total, including other postretirement losses	13	10
U.S. | Retiree health care plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	1	1
Interest cost	3	3
Expected return on plan assets	(3)	(3)
Recognized net actuarial loss	0	0
Net periodic benefit costs	1	1
Settlement losses	0	0
Total, including other postretirement losses	1	1
Non-U.S. | Defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	9	8
Interest cost	9	9
Expected return on plan assets	(20)	(18)
Recognized net actuarial loss	2	3
Net periodic benefit costs	0	2
Settlement losses	1	1
Total, including other postretirement losses	$ 1	$ 3

XML

Debt and lines of credit - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended
	Feb. 28, 2021	Mar. 31, 2021	Mar. 31, 2020
Debt Instrument [Line Items]
Commercial paper		$ 0
Retirement of debt		550,000,000	$ 0
Interest and debt expense		46,000,000	$ 45,000,000
Notes due 2021 at 2.75%
Debt Instrument [Line Items]
Retirement of debt	$ 550,000,000
Revolving credit facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 2,000,000,000

XML

Debt and lines of credit - Schedule of Long-term Debt Outstanding (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Total debt	$ 6,300	$ 6,850
Net unamortized discounts, premiums and issuance costs	(50)	(52)
Total debt, including net unamortized discounts, premiums and issuance costs	6,250	6,798
Current portion of long-term debt	0	(550)
Long-term debt	$ 6,250	6,248
Notes due 2021 at 2.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.75%
Total debt	$ 0	550
Notes due 2022 at 1.85%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.85%
Total debt	$ 500	500
Notes due 2023 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 500	500
Notes due 2024 at 2.625%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.625%
Total debt	$ 300	300
Notes due 2025 at 1.375%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.375%
Total debt	$ 750	750
Notes due 2027 at 2.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.90%
Total debt	$ 500	500
Notes due 2029 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 750	750
Notes due 2030 at 1.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.75%
Total debt	$ 750	750
Notes due 2039 at 3.875%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	3.875%
Total debt	$ 750	750
Notes due 2048 at 4.15%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.15%
Total debt	$ 1,500	$ 1,500

XML

Stockholders' equity - Schedule of Changes in Stockholders' Equity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	$ 9,187
Net income	(1,753)	$ (1,174)
Other comprehensive income (loss), net of taxes	13	19
Balance, ending	10,166
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	1,741	1,741
Balance, ending	1,741	1,741
Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	2,333	2,110
Common stock issued for stock-based awards	(3)	(77)
Stock compensation	61	63
Balance, ending	2,391	2,096
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	42,051	39,898
Net income	(1,753)	(1,174)
Dividends declared and paid	(940)	(841)
Dividend equivalents on RSUs	(4)	(4)
Balance, ending	42,860	40,227
Treasury Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	(36,578)	(34,495)
Common stock issued for stock-based awards	199	223
Stock repurchases	(100)	(1,730)
Balance, ending	(36,479)	(36,002)
AOCI
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	(360)	(347)
Other comprehensive income (loss), net of taxes	13	19
Balance, ending	$ (347)	$ (328)

XML

Stockholders' equity - Additional Information (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Equity [Abstract]
Cash dividends declared per common share (in dollars per share)	$ 1.02	$ 0.90
Cash dividends paid per common share (in dollars per share)	$ 1.02	$ 0.90

XML

Supplemental financial information - Amounts Reclassified out of AOCI (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2021	Mar. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)		$ 46	$ 25
Provision for income taxes		(186)	(50)
Net income		1,753	1,174
Reclassification out of Accumulated Other Comprehensive Income | Net actuarial losses of defined benefit plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)	[1]	11	10
Provision for income taxes		(3)	(2)
Net income		$ 8	$ 8

[1] Detailed in Note 5.

XML

Supplemental financial information - Additional Information (Details)	3 Months Ended
	Mar. 31, 2021 shares
Supplemental Financial Information [Abstract]
Treasury shares issued related to stock compensation (in shares)	4,465,552